Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VIYASH Viyash Scientific Limited Pharma · Micro | METROPOLIS Metropolis Healthcare Limited Pharma · Micro | INVICTA Invicta Diagnostic Ltd. Pharma · SME | NIDAN Nidan Laboratories And Healthcare Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 46 | 38 | 61 | 36 |
| Verdict | FAIR VALUE | WATCHLIST | UNDERVALUED | WATCHLIST |
| Style | Financial Turnaround | WATCHLIST | Growth at Value | WATCHLIST |
| Piotroski | 8/9 | 8/9 | 8/9 | 6/9 |
| Valuation | 2/30 | 0/30 | 19/30 | 20/30 |
| Growth | 14/25 | 8/25 | 22/25 | 4/25 |
| Quality | 5/20 | 9/20 | 8/20 | 0/20 |
| Balance Sheet | 12/15 | 9/15 | 13/15 | 8/15 |
| Cash Flow | 8/10 | 7/10 | 1/10 | 8/10 |
| Price | ₹260 | ₹534 | ₹61.2 | ₹14 |
| P/E | 55.10 | 56.00 | 16.40 | 11.10 |
| P/B | 3.78 | 7.26 | 1.62 | 0.28 |
| ROE | 11.00% | 13.80% | 14.70% | 2.55% |
| ROCE | 19.00% | 17.80% | 20.30% | 5.99% |
| Debt / Equity | 0.17 | 0.15 | 0.07 | 0.16 |
| FCF Yield | 2.17% | 1.16% | — | 8.87% |
| Dividend Y | — | 0.38% | — | — |
| Altman Z | 6.13 | 8.61 | 6.93 | 2.54 |
| Promoter % | 61.31% | 48.86% | 66.70% | 57.04% |
| Mkt Cap (₹Cr) | 11005.00 | 10990.00 | 80.80 | 19.50 |
| Graham # | ₹78 | ₹122.73 | ₹59.1 | ₹35.05 |
| Fair PE | 42.0 | 8.7 | 42.0 | 5.4 |
| MoS % | -52.5% | -568.5% | +62.7% | -137.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVIYASH124
METROPOLIS25
INVICTA71
NIDAN30